Tofacitinib for the treatment of lichen planopilaris: A case series

Christine C. Yang; Trisha Khanna; Brigitte Sallee; Angela M. Christiano; Lindsey A. Bordone

doi:10.1111/dth.12656

journal article Open Access Sep 27, 2018

Tofacitinib for the treatment of lichen planopilaris: A case series

Christine C. Yang

Trisha Khanna Brigitte Sallee Angela M. Christiano Lindsey A. Bordone

Dermatologic Therapy Vol. 31 No. 6 pp. e12656 · Wiley

View at Publisher Save 10.1111/dth.12656

Topics

No keywords indexed for this article. Browse by subject →

References

12

[1]

Hydroxychloroquine and lichen planopilaris: Efficacy and introduction of Lichen Planopilaris Activity Index scoring system

Charles Chiang, Deborah Sah, Bryan K. Cho et al.

Journal of the American Academy of Dermatology 2010 10.1016/j.jaad.2009.08.054

[2]

Craiglow "Tofacitinib citrate for the treatment of vitiligo" JAMA Dermatology (2015) 10.1001/jamadermatol.2015.1520

[3]

Kennedy "Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata" JCI Insight (2016)

[4]

Harries "Lichen planopilaris is characterized by immune privilege collapse of the hair follicles epithelial stem cell niche" The Journal of Pathology (2013) 10.1002/path.4233

[5]

Liu "Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients" Journal of the American Academy of Dermatology (2017) 10.1016/j.jaad.2016.09.007

[6]

Mackay-Wiggan "Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata" JCI Insight (2016) 10.1172/jci.insight.89790

[7]

Mamolo "Tofacitinib (CP-690,550), an oral Janus kinase inhibitor, improves patient-reported outcomes in a phase 2b, randomized, double-blind, placebo-controlled study in patients with moderate-to-severe psoriasis" Journal of the European Academy of Dermatology and Venereology (2015) 10.1111/jdv.12081

[8]

Medeiros "JAK3 as an emerging target for topical treatment of inflammatory skin diseases" PLoS One (2016) 10.1371/journal.pone.0164080

[9]

Papp "Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: A phase 2b randomized placebo-controlled dose-ranging study" British Journal of Dermatology (2012) 10.1111/j.1365-2133.2012.11168.x

[10]

Rácz "Treatment of frontal fibrosing alopecia and lichen planopilaris: A systematic review" Journal of the European Academy of Dermatology and Venereology (2013) 10.1111/jdv.12139

[11]

Rongioletti "Cicatricial (scarring) alopecias" American Journal of Clinical Dermatology (2012) 10.2165/11596960-000000000-00000

[12]

Xing "Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition" Nature Medicine (2014) 10.1038/nm.3645

Cited By

104

Successful treatment of recalcitrant cutaneous lichen planus and unusual variants with upadacitinib: A case series and a literature review of systemic Janus kinase inhibitors use in cutaneous lichen planus and lichen planopilaris

Megan E. McNamara, Leonardo Tjahjono · 2025

JAAD Case Reports

A Review on the Use and Effectiveness of JAK Inhibitor in the Management of Lichen Planopilaris

Therese Anne Limbana OMS, Caleb Sooknanan OMS · 2024

International Journal of Innovative...

Metrics

104

Citations

12

References

Details

Published: Sep 27, 2018
Vol/Issue: 31(6)
Pages: e12656
License: View

Authors

C

Christine C. Yang

Department of Dermatology; Columbia University Medical Center; New York New York

T

Trisha Khanna

Columbia University College of Physicians and Surgeons; New York New York

B

Brigitte Sallee

Department of Dermatology; Columbia University Medical Center; New York New York

A

Angela M. Christiano

Department of Dermatology; Columbia University Medical Center; New York New York; Department of Genetics and Development; Columbia University; New York New York

L

Lindsey A. Bordone

Department of Dermatology; Columbia University Medical Center; New York New York

Cite This Article

Christine C. Yang, Trisha Khanna, Brigitte Sallee, et al. (2018). Tofacitinib for the treatment of lichen planopilaris: A case series. Dermatologic Therapy, 31(6), e12656. https://doi.org/10.1111/dth.12656

Tofacitinib for the treatment of lichen planopilaris: A case series

You May Also Like